Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127769431 | 12776943 | 1 | I | 20101217 | 20110721 | 20160923 | 20160923 | EXP | US-ASTRAZENECA-2016SF01530 | ASTRAZENECA | 1.56 | YR | M | Y | 0.00000 | 20160923 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127769431 | 12776943 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 3 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 4 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 5 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 6 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 7 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 127769431 | 12776943 | 8 | C | BOSENTAN. | BOSENTAN | 1 | 0 | ||||||||||||
| 127769431 | 12776943 | 9 | C | SILDENAFIL. | SILDENAFIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127769431 | 12776943 | 1 | Antiviral prophylaxis |
| 127769431 | 12776943 | 2 | Antiviral prophylaxis |
| 127769431 | 12776943 | 3 | Antiviral prophylaxis |
| 127769431 | 12776943 | 4 | Antiviral prophylaxis |
| 127769431 | 12776943 | 5 | Antiviral prophylaxis |
| 127769431 | 12776943 | 6 | Antiviral prophylaxis |
| 127769431 | 12776943 | 7 | Antiviral prophylaxis |
| 127769431 | 12776943 | 8 | Pulmonary hypertension |
| 127769431 | 12776943 | 9 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127769431 | 12776943 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127769431 | 12776943 | Pneumonia | |
| 127769431 | 12776943 | Respiratory syncytial virus bronchiolitis | |
| 127769431 | 12776943 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127769431 | 12776943 | 1 | 20101029 | 20101029 | 0 | |
| 127769431 | 12776943 | 2 | 20101122 | 20101122 | 0 | |
| 127769431 | 12776943 | 3 | 20101221 | 20101221 | 0 | |
| 127769431 | 12776943 | 4 | 20110121 | 20110121 | 0 | |
| 127769431 | 12776943 | 5 | 20110218 | 20110218 | 0 | |
| 127769431 | 12776943 | 6 | 20110318 | 20110318 | 0 | |
| 127769431 | 12776943 | 7 | 20110418 | 20110418 | 0 |